CD4 and neoplasm: These results suggest that both NK cells and CD4+ T cells are each required to mediate rejection of these MHC-I-negative tumor challenges; while the CD4 + T helper cells have likely encountered tumor antigen on host MHC-II-positive APCs, the exact roles of the NK cells and the CD4+ T cells in tumor destruction have not been completely resolved.